Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02728635 · ClinicalTrials.gov registry record · NA

Epigenetic Regulation of Human Adipose Tissue Distribution

A NA study of Obesity, sponsored by AdventHealth Translational Research Institute.

Active
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT02728635 is a NA study of Obesity that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 27 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02728635, a NA study of Obesity, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect data to help researchers better understand the different ways that women or men store fat (apple shape versus pear shape).

Conditions Studied

Interventions

  • OTHER Dual-energy X-ray absorptiometry (DEXA)/ Magnetic resonance imaging (MRI) and Magnetic resonance spectroscopy (MRS)
  • PROCEDURE Adipose tissue biopsies
  • OTHER FSIGTT/ RMR

Study Locations (1)

Florida

  • Translational Research Institute for Metabolism and Diabetes - Orlando

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2016-07
Est. Completion 2025-12
Phase NA

What the Registry Record Tells You About NCT02728635

The ClinicalTrials.gov registry entry for NCT02728635 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Dual-energy X-ray absorptiometry (DEXA)/ Magnetic resonance imaging (MRI) and Magnetic resonance spectroscopy (MRS) is the first listed.

NCT02728635 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02728635 about?

NCT02728635 is a clinical study titled "Epigenetic Regulation of Human Adipose Tissue Distribution". The purpose of this study is to collect data to help researchers better understand the different ways that women or men store fat (apple shape versus pear shape).

What is the current status of trial NCT02728635?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 27 participants. The study started on 2016-07. Estimated completion is 2025-12.

What conditions does trial NCT02728635 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02728635?

The interventions under investigation include: Dual-energy X-ray absorptiometry (DEXA)/ Magnetic resonance imaging (MRI) and Magnetic resonance spectroscopy (MRS) (OTHER), Adipose tissue biopsies (PROCEDURE), FSIGTT/ RMR (OTHER).

Who is sponsoring clinical trial NCT02728635?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02728635 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.